ANDREW KENNEY

-Safe Step Act -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform

Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.

Resident Physician Shortage Reduction Act Conrad State 30 and Physician Access Reauthorization Act Resident Education Deferred Interest Act Safe Step Act - Improving Seniors Timely Access to Care Act H-1Bs for the Physicians and Healthcare Workforce Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States

Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth - VA neurology workforce issues

Telehealth Modernization Act CONNECT for Health Act of 2025 Strengthening Medicare for Patients and Providers Act Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization